A NIR fluorescent probe for fatty acid amide hydrolase bioimaging and its application in development of inhibitors

被引:9
|
作者
Tian, Manman [1 ]
Tian, Zhenhao [3 ]
Yao, Dahong [4 ]
Ning, Jing [1 ]
Deng, Sa [1 ]
Feng, Lei [1 ,5 ]
Huo, Xiaokui [1 ]
Tian, Xiangge [1 ]
Zhang, Baojing [1 ]
Wang, Chao [1 ]
Yu, Zhenlong [1 ]
Ma, Xiaochi [1 ,2 ]
机构
[1] Dalian Med Univ, Affiliated Hosp 2, Coll Pharm, Dalian, Peoples R China
[2] Xuzhou Med Univ, Jiangsu Key Lab New Drug Res & Clin Pharm, Xuzhou 221004, Jiangsu, Peoples R China
[3] Northwestern Polytech Univ, Sch Life Sci, Xian 710072, Peoples R China
[4] Shenzhen Technol Univ, Sch Pharmaceut Sci, Shenzhen 518118, Peoples R China
[5] Henan Normal Univ, Sch Chem & Chem Engn, Xinxiang 453007, Henan, Peoples R China
基金
中国国家自然科学基金;
关键词
CLINICAL-TRIAL; FAAH; ENZYME; PAIN;
D O I
10.1039/d1tb01054a
中图分类号
TB3 [工程材料学]; R318.08 [生物材料学];
学科分类号
0805 ; 080501 ; 080502 ;
摘要
Fatty acid amide hydrolase (FAAH) is primarily responsible for the inactivation of fatty acid ethanolamide (FAE) and is involved in a variety of biological functions related to diseases of the nervous system. Herein, we developed a highly selective and sensitive FAAH-activated near-infrared fluorescent probe named DAND and achieved the real-time detection and imaging of FAAH activity in complex biosystems. Moreover, a visual high-throughput screening method was established using DAND, piperine was identified as a novel inhibitor of FAAH. Based on the interaction of piperine with FAAH, a more potent FAAH inhibitor (11f) was designed and synthesized which possessed an IC50 value of 0.65 mu M. Furthermore, 11f could attenuate the liposaccharide (LPS)-induced activation of BV2 cells, exhibiting an excellent anti-inflammatory activity. These results indicated that DAND could be used as a promising molecular tool for exploring FAAH activity and for rapidly screening potential FAAH inhibitors. In addition, piperine and its derivatives could serve as potential candidate drugs for the treatment of neurodegenerative diseases in the future.
引用
收藏
页码:6460 / 6465
页数:6
相关论文
共 50 条
  • [31] Design and Potency of Dual Soluble Epoxide Hydrolase/Fatty Acid Amide Hydrolase Inhibitors
    Kodani, Sean D.
    Wan, Debin
    Wagner, Karen M.
    Hwang, Sung Hee
    Morisseau, Christophe
    Hammock, Bruce D.
    ACS OMEGA, 2018, 3 (10): : 14076 - 14086
  • [32] Recent advances in the discovery and evaluation of fatty acid amide hydrolase inhibitors
    Deng, Hongfeng
    EXPERT OPINION ON DRUG DISCOVERY, 2010, 5 (10) : 961 - 993
  • [33] Heteroarylureas with spirocyclic diamine cores as inhibitors of fatty acid amide hydrolase
    Keith, John M.
    Jones, William M.
    Pierce, Joan M.
    Seierstad, Mark
    Palmer, James A.
    Webb, Michael
    Karbarz, Mark J.
    Scott, Brian P.
    Wilson, Sandy J.
    Luo, Lin
    Wennerholm, Michelle L.
    Chang, Leon
    Brown, Sean M.
    Rizzolio, Michele
    Rynberg, Raymond
    Chaplan, Sandra R.
    Breitenbucher, J. Guy
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (03) : 737 - 741
  • [34] Developing novel fatty acid amide hydrolase inhibitors for the treatment of pain
    Faloon, Jordan
    Ezzili, Cyrine
    Giuvelis, Denise
    Lowery, John J.
    McGlinchey, Nicholas
    Boger, Dale
    Bilsky, Edward J.
    FASEB JOURNAL, 2011, 25
  • [35] Optimization of the central heterocycle of α-ketoheterocycle inhibitors of fatty acid amide hydrolase
    Garfunkle, Joie
    Ezzili, Cyrine
    Rayl, Thomas J.
    Hochstatter, Dustin G.
    Hwang, Inkyu
    Boger, Dale L.
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (15) : 4392 - 4403
  • [36] Discovery of Uracil Derivatives as Potent Inhibitors of Fatty Acid Amide Hydrolase
    Qiu, Yan
    Zhang, Yang
    Li, Yuhang
    Ren, Jie
    MOLECULES, 2016, 21 (02)
  • [37] Identification of potent, noncovalent fatty acid amide hydrolase (FAAH) inhibitors
    Gustin, Darin J.
    Ma, Zhihua
    Min, Xiaoshan
    Li, Yihong
    Hedberg, Christine
    Guimaraes, Cris
    Porter, Amy C.
    Lindstrom, Michelle
    Lester-Zeiner, Dianna
    Xu, Guifen
    Carlson, Timothy J.
    Xiao, Shouhua
    Meleza, Cesar
    Connors, Richard
    Wang, Zhulun
    Kayser, Frank
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (08) : 2492 - 2496
  • [38] (Indolylalkyl) piperidine carbamates as inhibitors of fatty acid amide hydrolase (FAAH)
    Dahlhaus, Helmut
    Hanekamp, Walburga
    Lehr, Matthias
    MEDCHEMCOMM, 2017, 8 (03) : 616 - 620
  • [39] Novel ketooxazole based inhibitors of fatty acid amide hydrolase (FAAH)
    Timmons, Amy
    Seierstad, Mark
    Apodaca, Rich
    Epperson, Matt
    Pippel, Dan
    Brown, Sean
    Chang, Leon
    Scott, Brian
    Webb, Michael
    Chaplan, Sandra R.
    Breitenbucher, J. Guy
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (06) : 2109 - 2113
  • [40] α-Ketoheterocycle-Based Inhibitors of Fatty Acid Amide Hydrolase (FAAH)
    Otrubova, Katerina
    Boger, Dale L.
    ACS CHEMICAL NEUROSCIENCE, 2012, 3 (05): : 340 - 348